← Open Payments lookup

EMMA LUTZ: Open Payments

NPI 1477263911 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$436 in 10 payments from 7 companies in 2025. Trend: 2023 $917 · 2024 $708 · 2025 $436

Food & beverage: $436
CompanyPaymentsAmount
Lundbeck LLC1$136
Biogen, Inc.1$125
ABBVIE INC.3$76
Gilead Sciences, Inc.2$39
Lilly USA, LLC1$27
Indivior Inc.1$17
Novo Nordisk Inc1$16

Products named: VYEPTI, SPINRAZA, MAVYRET, QULIPTA, MOUNJARO, SUBLOCADE, Ozempic.

Industry payments across CA — which companies pay providers there.